Recommendation 30. We recommend that patients who have concomitant symptomatic CAD and another condition requiring OAC receive a regimen of antithrombotic therapy that is based on a balanced assessment of their risk of: (1) systemic embolism; (2) future coronary event(s); and (3) clinically significant bleeding associated with the use of antithrombotic agents (Strong Recommendation; High-Quality Evidence).